Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:772-777, doi:10.1016/j.jacc.2006.10.053 (Published online 6 February 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.10.053v1
49/7/772    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leroyer, A. S.
Right arrow Articles by Boulanger, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leroyer, A. S.
Right arrow Articles by Boulanger, C. M.

CLINICAL RESEARCH: ATHEROSCLEROSIS

Cellular Origins and Thrombogenic Activity of Microparticles Isolated From Human Atherosclerotic Plaques

Aurélie S. Leroyer, BSc*, Hirotaka Isobe, PhD{dagger}, Guy Lesèche, MD, PhD{ddagger}, Yves Castier, MD, PhD{ddagger}, Michel Wassef, PhD§, Ziad Mallat, MD, PhD*, Bernd R. Binder, MD, PhD{dagger}, Alain Tedgui, PhD* and Chantal M. Boulanger, PhD*,*

* INSERM Cardiovascular Research Center Lariboisière, Paris, France
{dagger} Department of Vascular Biology and Thrombosis Research, Medical University, Vienna, Austria
{ddagger} Vascular Surgery Department, Beaujon Hospital, Clichy, France
§ Lariboisière Hospital, Paris, France

Manuscript received April 24, 2006; revised manuscript received September 8, 2006, accepted October 9, 2006.

* Reprint requests and correspondence: Dr. Chantal M. Boulanger, INSERM CRC Lariboisière, 41 bd Chapelle, 75475 Paris, France. (Email: chantal.boulanger{at}larib.inserm.fr).

OBJECTIVES: In this study, we evaluated the cellular origins and thrombogenic potential of microparticles.

BACKGROUND: Human atherosclerotic plaques contain submicron vesicles (microparticles) released during cell activation or apoptosis.

METHODS: Microparticles were purified from plaques and platelet-free plasma from 26 patients undergoing carotid endarterectomy. Flow cytometry analysis revealed the presence of large amounts of microparticles in plaques but not in healthy vessels.

RESULTS: Most plaque microparticles originated from leukocytes, of which 29 ± 5% were macrophages, 15 ± 3% lymphocytes, and 8 ± 1% granulocytes. Plaques microparticles also derived from erythrocytes (27 ± 4%), smooth muscle (13 ± 4%) and endothelial cells (8 ± 2%), but not from platelets. Plaques from asymptomatic and symptomatic patients showed no differences in microparticle origins. Microparticles were at least 200-fold more concentrated in plaque than in plasma. Plasma microparticles were primarily platelet-derived in contrast with those of plaque and showed no smooth muscle cell origin. Both plaque and plasma microparticles exposed tissue factor and generated thrombin, but this activity was twice as high in microparticles isolated from plaques, reflecting the thrombogenic contribution of the individual classes of microparticles.

CONCLUSIONS: These results demonstrate that microparticles are more abundant and more thrombogenic in human atherosclerotic plaques than in plasma. The different cellular origins of plaque and plasma microparticles might explain the increased thrombogenic activity of plaque microparticles.

Abbreviations and Acronyms
  IgG = immunoglobulin G
  MPs = microparticles
  PFP = platelet-free plasma
  RBC = red blood cell
  SMA = smooth muscle cell actin
  SMC = smooth muscle cell
  TF = tissue factor
  TGA = thrombin-generating activity




This article has been cited by other articles:


Home page
haematolHome page
F. Angelot, E. Seilles, S. Biichle, Y. Berda, B. Gaugler, J. Plumas, L. Chaperot, F. Dignat-George, P. Tiberghien, P. Saas, et al.
Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases
Haematologica, November 1, 2009; 94(11): 1502 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
M. Mayr, D. Grainger, U. Mayr, A. S. Leroyer, G. Leseche, A. Sidibe, O. Herbin, X. Yin, A. Gomes, B. Madhu, et al.
Proteomics, Metabolomics, and Immunomics on Microparticles Derived From Human Atherosclerotic Plaques
Circ Cardiovasc Genet, August 1, 2009; 2(4): 379 - 388.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Prokopi, G. Pula, U. Mayr, C. Devue, J. Gallagher, Q. Xiao, C. M. Boulanger, N. Westwood, C. Urbich, J. Willeit, et al.
Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures
Blood, July 16, 2009; 114(3): 723 - 732.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Simoncini, M.-S. Njock, S. Robert, L. Camoin-Jau, J. Sampol, J.-R. Harle, C. Nguyen, F. Dignat-George, and F. Anfosso
TRAIL/Apo2L Mediates the Release of Procoagulant Endothelial Microparticles Induced by Thrombin In Vitro: A Potential Mechanism Linking Inflammation and Coagulation
Circ. Res., April 24, 2009; 104(8): 943 - 951.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Wang, C. Miller, R. F. Swarthout, M. Rao, N. Mackman, and M. B. Taubman
Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury
Blood, January 15, 2009; 113(3): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Leroyer, P.-E. Rautou, J.-S. Silvestre, Y. Castier, G. Leseche, C. Devue, M. Duriez, R. P. Brandes, E. Lutgens, A. Tedgui, et al.
CD40 Ligand+ Microparticles From Human Atherosclerotic Plaques Stimulate Endothelial Proliferation and Angiogenesis: A Potential Mechanism for Intraplaque Neovascularization
J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1302 - 1311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Jayachandran, R. D. Litwiller, W. G. Owen, J. A. Heit, T. Behrenbeck, S. L. Mulvagh, P. A. Araoz, M. J. Budoff, S. M. Harman, and V. M. Miller
Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H931 - H938.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Li
Platelet-lymphocyte cross-talk
J. Leukoc. Biol., May 1, 2008; 83(5): 1069 - 1078.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. A. Mostefai, A. Agouni, N. Carusio, M. L. Mastronardi, C. Heymes, D. Henrion, R. Andriantsitohaina, and M. C. Martinez
Phosphatidylinositol 3-Kinase and Xanthine Oxidase Regulate Nitric Oxide and Reactive Oxygen Species Productions by Apoptotic Lymphocyte Microparticles in Endothelial Cells
J. Immunol., April 1, 2008; 180(7): 5028 - 5035.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Canault, A. S. Leroyer, F. Peiretti, G. Leseche, A. Tedgui, B. Bonardo, M.-C. Alessi, C. M. Boulanger, and G. Nalbone
Microparticles of Human Atherosclerotic Plaques Enhance the Shedding of the Tumor Necrosis Factor-{alpha} Converting Enzyme/ADAM17 Substrates, Tumor Necrosis Factor and Tumor Necrosis Factor Receptor-1
Am. J. Pathol., November 1, 2007; 171(5): 1713 - 1723.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Mackman, R. E. Tilley, and N. S. Key
Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and Thrombosis
Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1687 - 1693.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement